Literature DB >> 15896703

The kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate.

Nathan P Manes1, M Raafat El-Maghrabi.   

Abstract

The two enzymatic activities of the highly conserved catalytic core of 6PF2K/Fru-2,6-P(2)ase are thought to be reciprocally regulated by the amino- and carboxy-terminal regions unique to each isoform. In this study, we describe the recombinant expression, purification, and kinetic characterization of two human brain 6PF2K/Fru-2,6-P(2)ase splice variants, HBP1 and HBP2. Interestingly, both lack an arginine which is highly conserved among other tissue isoforms, and which is understood to be critical to the fructose-2,6-bisphosphatase mechanism. As a result, the phosphatase activity of both HBP isoforms is negligible, but we found that it could be recovered by restoration of the arginine by site directed mutagenesis. We also found that AMP activated protein kinase and protein kinases A, B, and C catalyzed the phosphorylation of Ser-460 of HBP1, and that in addition both isoforms are phosphorylated at a second, as yet undetermined site by protein kinase C. However, none of the phosphorylations had any effect on the intrinsic kinetic characteristics of either enzymatic activity, and neither did point mutation (mimicking phosphorylation), deletion, and alternative-splice modification of the HBP1 carboxy-terminal region. Instead, these phosphorylations and mutations decreased the sensitivity of the 6PF2K to a potent allosteric inhibitor, phosphoenolpyruvate, which appears to be the major regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896703     DOI: 10.1016/j.abb.2005.04.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  Molecular basis of the fructose-2,6-bisphosphatase reaction of PFKFB3: transition state and the C-terminal function.

Authors:  Michael C Cavalier; Song-Gun Kim; David Neau; Yong-Hwan Lee
Journal:  Proteins       Date:  2012-01-31

2.  mTORC2 mediates CXCL12-induced angiogenesis.

Authors:  Mary E Ziegler; Michaela M S Hatch; Nan Wu; Steven A Muawad; Christopher C W Hughes
Journal:  Angiogenesis       Date:  2016-04-22       Impact factor: 9.596

3.  Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.

Authors:  Nadiia Lypova; Sucheta Telang; Jason Chesney; Yoannis Imbert-Fernandez
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

Review 4.  Targeting cancer metabolism: a therapeutic window opens.

Authors:  Matthew G Vander Heiden
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

Review 5.  The role of PFKFB3 in maintaining colorectal cancer cell proliferation and stemness.

Authors:  Siyuan Yan; Qianqian Li; Shi Li; Zhiying Ai; Dongdong Yuan
Journal:  Mol Biol Rep       Date:  2022-05-12       Impact factor: 2.742

Review 6.  Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.

Authors:  Brandon C Jones; Paula R Pohlmann; Robert Clarke; Surojeet Sengupta
Journal:  Cancer Metastasis Rev       Date:  2022-04-14       Impact factor: 9.237

Review 7.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858

8.  Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer.

Authors:  Brian F Clem; Julie O'Neal; Gilles Tapolsky; Amy L Clem; Yoannis Imbert-Fernandez; Daniel A Kerr; Alden C Klarer; Rebecca Redman; Donald M Miller; John O Trent; Sucheta Telang; Jason Chesney
Journal:  Mol Cancer Ther       Date:  2013-05-14       Impact factor: 6.261

9.  Phosphoenolpyruvate-dependent inhibition of collagen biosynthesis, alpha2beta1 integrin and IGF-I receptor signaling in cultured fibroblasts.

Authors:  Ewa Karna; Jerzy A Palka
Journal:  Mol Cell Biochem       Date:  2008-05-21       Impact factor: 3.396

10.  Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.

Authors:  Alden C Klarer; Julie O'Neal; Yoannis Imbert-Fernandez; Amy Clem; Steve R Ellis; Jennifer Clark; Brian Clem; Jason Chesney; Sucheta Telang
Journal:  Cancer Metab       Date:  2014-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.